Covid-19 Vaccines For Kids: DCGI Grants Emergency Use Nod To 3 Vaccines For Different Age Group Of Children

Add as a preferred source on Google

On Tuesday (26 April), the Drugs Controller General of India (DCGI) approved three Covid-19 vaccines for restricted emergency use authorisation (EUA) in children of various ages.

Bharat Biotech's Covaxin received a restricted EUA from the DCGI for children aged 6 to12. Similarly, Biological E's Covid-19 vaccine Corbevax has been approved for children aged 5 to 12 years.

Further, along with Corbevax and Covaxin, the DCGI has also approved Zydus Cadila's Covid-19 vaccine ZyCoV-D for children over the age of 12 years for a two-dose regimen.

This development happened after the Subject Expert Committee's (SEC) discussion of suggestions for the emergency use of Covaxin in children aged 6 to 12 years due to an increase in covid-19 cases in schools.

Covaxin has proven to be effective for adults and is also presently being given to youngsters aged 15 to 18. To give EUA to Covaxin for children aged 6-12 years, experts had requested more information from the corporation, which was delivered on Friday. The SEC was satisfied with the provided data and thus, nods for its EUA among children aged 6-12 years.

As the focus was mainly on the increasing number of cases among children, the SEC has also recommended emergency use of Biological E's Covid-19 vaccine Corbevax and ZyCoV-D.